Immuneering (IMRX) Change in Cash (2020 - 2024)
Historic Change in Cash for Immuneering (IMRX) over the last 5 years, with Q4 2024 value amounting to -$9.1 million.
- Immuneering's Change in Cash fell 493.85% to -$9.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$23.3 million, marking a year-over-year decrease of 7580.66%. This contributed to the annual value of -$23.3 million for FY2024, which is 7580.66% down from last year.
- Latest data reveals that Immuneering reported Change in Cash of -$9.1 million as of Q4 2024, which was down 493.85% from -$14.5 million recorded in Q3 2024.
- In the past 5 years, Immuneering's Change in Cash ranged from a high of $56.7 million in Q3 2021 and a low of -$36.0 million during Q3 2023
- For the 5-year period, Immuneering's Change in Cash averaged around $1.5 million, with its median value being -$3.6 million (2020).
- Per our database at Business Quant, Immuneering's Change in Cash surged by 172338.02% in 2021 and then tumbled by 21231.24% in 2023.
- Immuneering's Change in Cash (Quarter) stood at $31.5 million in 2020, then plummeted by 201.74% to -$32.0 million in 2021, then soared by 88.2% to -$3.8 million in 2022, then crashed by 128.37% to -$8.6 million in 2023, then fell by 4.94% to -$9.1 million in 2024.
- Its Change in Cash stands at -$9.1 million for Q4 2024, versus -$14.5 million for Q3 2024 and -$6.6 million for Q2 2024.